Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 257-262

  Firtser, Sonja ^a   Juonala, Markus ^a,b   Magnussen, Costan G ^a,e   Jula, Antti ^c   Loo, Britt Marie ^c   Marniemi, Jukka ^c   Viikari, Jorma S A ^b   Toppari, Jorma ^b   Perheentupa, Antti ^b   Hutri Kähönen, Nina ^d   Raitakari, Olli T ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Calculated free testosterone; Cardiovascular risk factors; SHBG; Total testosterone

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ADULT; AGING; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FINLAND; HUMANS; INSULIN; MALE; MIDDLE AGED; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES;

EID: 84859812881     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.020     Document Type: Article

References (32)

1. Gapstur S.M., Gann P.H., Kopp P., Colangelo L., Longcope C., Liu K. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002, 11:1041-1047.
2. Leifke E., Gorenoi V., Wichers C., Von Zur Muhlen A., Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex hormone-binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000, 53:689-695.
3. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989, 10:232-274.
4. Umstot E.S., Baxter J.E., Andersen R.N. A theoretically sound and practicable equilibrium dialysis method for measuring percentage of free testosterone. J Steroid Biochem 1985, 22:639-648.
5. Vlahos I., MacMahon W., Sgoutas D., Bowers W., Thompson J., Trawick W. An improved ultrafiltration method for determining free testosterone in serum. Clin Chem 1982, 28:2286-2291.
6. Ding E.L., Song Y., Malik V.S., Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299.
7. Laaksonen D.E., Niskanen L., Punnonen K., et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003, 149:601-608.
8. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005, 26:833-876.
9. Blouin K., Boivin A., Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008, 108:272-280.
10. Muller M., van der Schouw Y.T., Thijssen J.H., Grobbee D.E. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab 2003, 88:5076-5086.
11. Mäkinen J.I., Perheentupa A., Irjala K., et al. Endogenous testosterone and serum lipids in middle-aged men. Atherosclerosis 2008, 197:688-693.
12. Raitakari O.T., Juonala M., Rönnemaa T., et al. Cohort profile: the Cardiovascular Risk in Young Finns Study. Int J Epidemiol 2008, 37:1220-1226.
13. Raiko J.R., Viikari J.S., Ilmanen A., et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010, 267:370-384.
14. Ly L.P., Handelsman D.J. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 2005, 152:471-478.
15. Sartorius G., Ly L.P., Sikaris K., McLachlan R., Handelsman D.J. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 2009, 46:137-143.
16. Telama R., Yang X., Viikari J., Välimäki I., Wanne O., Raitakari O. Physical activity from childhood to adulthood: a 21-year tracking study. Am J Prev Med 2005, 28:267-273.
17. Travison T.G., Araujo A.B., Kupelian V., O'Donnell A.B., McKinlay J.B. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 2007, 92:549-555.
18. Li C., Ford E.S., Li B., Giles W.H., Li S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010, 33:1618-1624.
19. Chubb S.A., Hyde Z., Almeida O.P., et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol 2008, 158:785-792.
20. Khaw K.T., Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb 1991, 11:489-494.
21. Svartberg J., von Muhlen D., Schirmer H., Barrett-Connor E., Sundfjord J., Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Eur J Endocrinol 2004, 150:65-71.
22. Lindholm J., Winkel P., Brodthagen U., Gyntelberg F. Coronary risk factors and plasma sex hormones. Am J Med 1982, 73:648-651.
23. Zmuda J.M., Cauley J.A., Kriska A., Glynn N.W., Gutai J.P., Kuller L.H. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants. Am J Epidemiol 1997, 146:609-617.
24. Cohen P.G. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 2001, 56:702-708.
25. Osuna J.A., Gomez-Perez R., Arata-Bellabarba G., Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 2006, 52:355-361.
26. Jones T.H., Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009, 207:318-327.
27. Porto C.S., Lazari M.F., Abreu L.C., Bardin C.W., Gunsalus G.L. Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol 1995, 53:561-565.
28. Kahn S.M., Hryb D.J., Nakhla A.M., Romas N.A., Rosner W. Sex hormone-binding globulin is synthesized in target cells. J Endocrinol 2002, 175:113-120.
29. Ding E.L., Song Y., Manson J.E., et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009, 361:1152-1163.
30. Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., Romas N.A. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 1999, 69:481-485.
31. Rosner W., Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010, 95:4542-4548. Endocrine Society.
32. Wartofsky L., Handelsman D.J. Standardization of hormonal assays for the 21st century. J Clin Endocrinol Metab 2010, 95:5141-5143.